Bryan, Garnier & Co
Bryan, Garnier & Co was a European middle-market investment bank specializing in healthcare and technology advisory. It provided M&A, capital markets, and equity research services to corporates and institutional investors across Europe and North America before its February 2025 acquisition by Stifel.
- Company typePrivate
- Founded1995
- HeadquartersParis, France
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Bryan, Garnier & Co does
Bryan, Garnier & Co is a European independent investment bank founded in 1995 and headquartered in Paris, with an additional principal office in London. The firm focused on middle-market advisory in two core verticals — healthcare (including medtech and biopharma) and technology (including software and tech-enabled services) — serving corporate clients and institutional investors across Europe and, through trans-Atlantic execution capabilities, North America. Service lines spanned private buy-side and sell-side M&A, public takeovers and defense, strategic advisory, IPO advisory, rights issues, equity private placements, debt and equity capital markets, and equity research, sales and trading; pricing was transaction-based with success fees and multi-year corporate broking relationships (particularly on the UK Main Market and AIM). The firm pursued an active inorganic growth strategy, acquiring Cartagena Capital (2016), Beringer Finance (2019), Brocair Partners (2019), and NOR Capital (2023) prior to its own sale. On 2025-02-06, Stifel Financial Corp. completed the acquisition of Bryan, Garnier & Co, integrating the franchise into its European platform and reabsorbing its research and thought-leadership output into the Stifel IRIS content platform; the firm no longer operates as an independent entity.
Bryan, Garnier & Co firmographics
Firmographics- Name
- Bryan, Garnier & Co
- Legal name
- Bryan, Garnier & Co.
- Website
- https://bryangarnier.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Bryan, Garnier & Co was a European middle-market investment bank specializing in healthcare and technology advisory. It provided M&A, capital markets, and equity research services to corporates and institutional investors across Europe and North America before its February 2025 acquisition by Stifel.
- Ownership category
- akta.pro rank
Bryan, Garnier & Co industry classification
Industry- Product category
- Investment Banking Services
- NAICS
- Investment Banking and Securities Intermediation (52315), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
- SIC
- Services-Engineering, Accounting, Research, Management (8700), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ)
- akta.pro secondary industries
- M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Corporate Finance Advisory (Strategic Finance, Capital Structure & Recaps) (FSAEAGAE), Cross-Border M&A Advisory (FSAEAGAH)
Keywords
Where Bryan, Garnier & Co is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Bryan, Garnier & Co business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Investment Banking Advisory: M&A advisory, strategic advisory, and transaction execution for middle-market companies in healthcare and technology verticals. Services include private buy-side and sell-side M&A, public takeovers, IPO advisory, rights issues, and equity private placements.
- Capital Markets: Debt and equity capital markets solutions including investment and sub-investment grade financings, and capital markets advisory.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | M&A Advisory Services |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Bryan, Garnier & Co product offering
Product offeringCore offering
Bryan, Garnier & Co is a European middle-market investment bank that provides M&A advisory, capital markets solutions, equity research, and sales & trading services. The firm specializes in the healthcare and technology verticals, serving dynamic mid-market companies and institutional investors across Europe with trans-Atlantic advisory capabilities connecting European companies to North American capital markets.
Product overview
Bryan, Garnier & Co was a European middle market investment bank specializing in the healthcare and technology verticals. The firm provided advisory services and was subsequently acquired by Stifel in February 2025. Post-acquisition, the firm operates as part of Stifel's European operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Investment Banking Advisory Full-service investment banking advisory covering M&A (private buy-side and sell-side), public takeovers and defense, strategic advisory, investor positioning, IPOs, rights issues, and equity private placements. Serves mid-market healthcare and technology companies across Continental Europe, North America, the Middle East, and Asia.
- Capital Solutions London-based Capital Solutions Group providing full range of public and private capital markets solutions including investment and sub-investment grade financings, complex and distressed situations, debt financing structures, restructuring and liability management. Leverages Stifel's global coverage of more than 8,000 accounts from large institutions to private wealth.
- UK Corporate Broking UK corporate broking service offering retained relationships with companies listed on the Main Market and AIM, providing equity capital markets support, M&A advice, defense advisory, and debt capital markets insight. Active across Healthcare, Technology, Financials, Real Estate, Energy and Resources, and Investment Funds sectors.
- Equity Research, Sales & Trading Pan-European equity research, sales and trading product providing forward-thinking research and analysis through articles, white papers, quarterly reports, and market insights via the Stifel IRIS platform, covering mid-cap companies for institutional investors.
Companies that use Bryan, Garnier & Co
Customer profileSegments3 records
Ideal customer profiles3 records
Bryan, Garnier & Co technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bryan, Garnier & Co partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Bryan, Garnier & Co competitors and assessment
Company assessmentDirect peers
- Rothschild & Co: European-headquartered independent advisory firm with deep M&A and capital markets capabilities across mid-cap healthcare, technology, and industrials. Highly comparable business model and client base to Bryan Garnier.
- William Blair: US-based middle-market investment bank with strong healthcare and technology sector practices. Comparable vertical-specialist mid-market positioning with cross-border capability similar to Bryan Garnier's trans-Atlantic focus.
- Lazard: Global independent investment bank with strong M&A advisory franchise and significant European mid-market healthcare and technology coverage. Direct competitor for sell-side and buy-side mandates in Bryan Garnier's core verticals.
- Evercore: Independent advisory-focused investment bank with strong M&A franchise in healthcare and technology. Comparable advisory-driven model and middle-to-upper-middle market positioning.
- Jefferies: Middle-market investment bank with significant European operations and dedicated healthcare and technology coverage. Competes for many of the same cross-border mid-cap advisory mandates as Bryan Garnier.
- DC Advisory: European-headquartered mid-market M&A advisor with sector specializations overlapping Bryan Garnier's healthcare and technology verticals. Closely comparable boutique advisory model.
Regional players
- Mediobanca: Italy-headquartered independent investment bank with strong European mid-cap M&A advisory and equity research franchises. Comparable European mid-market advisory positioning with sector-agnostic but adjacent verticals.
Emerging players
- Oakley Advisory: European independent advisory boutique with focus on mid-market M&A in healthcare, technology, and consumer. Smaller scale but directly comparable boutique advisory model and vertical focus.
- Arma Partners: European independent advisory firm specializing in technology and digital media M&A. Niche player with comparable boutique focus on European tech mandates.
Broad incumbents
- Numis (Deutsche Bank): UK mid-market investment bank acquired by Deutsche Bank, with strong healthcare and technology sector coverage in UK and European mid-caps. Recently transitioned from independent to incumbent platform, mirroring Bryan Garnier's Stifel path.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Bryan, Garnier & Co social profiles
Digital presenceBryan, Garnier & Co financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bryan, Garnier & Co leadership team
Management profileNumber of profiles
Profiles4 records
Bryan, Garnier & Co funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bryan, Garnier & Co M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bryan, Garnier & Co
What does Bryan, Garnier & Co do?
Bryan, Garnier & Co is a European middle-market investment bank that provides M&A advisory, capital markets solutions, equity research, and sales & trading services. The firm specializes in the healthcare and technology verticals, serving dynamic mid-market companies and institutional investors across Europe with trans-Atlantic advisory capabilities connecting European companies to North American capital markets.
Is Bryan, Garnier & Co a public or private company?
Bryan, Garnier & Co is a private company. It is classified as corporate owned and is currently acquired.
When was Bryan, Garnier & Co founded?
Bryan, Garnier & Co was founded in 1995. It employs 101 to 250 people.
Where is Bryan, Garnier & Co based?
Bryan, Garnier & Co is headquartered in Paris, France, in the Europe region.
How does Bryan, Garnier & Co make money?
Two revenue lines are on record. Investment Banking Advisory is the primary driver. The others are capital Markets.
Who are Bryan, Garnier & Co's main competitors?
Direct peers on record are Rothschild & Co, William Blair, Lazard, Evercore, Jefferies and DC Advisory. Mediobanca is listed as a regional player. Emerging players are Oakley Advisory and Arma Partners. Numis (Deutsche Bank) is listed as a broad incumbent.
Does Bryan, Garnier & Co have an API?
No public API is recorded for Bryan, Garnier & Co.
What industry is Bryan, Garnier & Co in?
Bryan, Garnier & Co's product category is Investment Banking Services. Its primary akta.pro industry code is FSAEAGAJ, Industry-Specialist / Sector-Focused M&A Advisory, with a secondary code of BPAHAOAA, M&A Advisory (Buy-Side & Sell-Side). Its NAICS code is 52315 and its SIC code is 8700.